...
首页> 外文期刊>Molecular imaging and biology: MIB : the official publication of the Academy of Molecular Imaging >Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI
【24h】

Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI

机译:评估酰胺质子转移(APT) - 重量对比度,优化术语的作用,对肿瘤和感染质量病变的分化,在3T MRI的分化中

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose To evaluate the role of amide proton transfer-weighted (APT-w) magnetic resonance imaging (MRI) in differentiating neoplastic and infective mass lesions using different contrast normalizations, region of interest (ROI) selection, and histogram analysis. Procedures Retrospective study included 32 treatment-naive patients having intracranial mass lesions (ICMLs): low-grade glioma (LGG) = 14, high-grade glioma (HGG) = 10, and infective mass lesions = 8. APT-w MRI images were acquired along with conventional MRI images at 3 T. APT-w contrast, corrected for B-0-field inhomogeneity, was computed and optimized with respect to different types of normalizations. Different ROIs on lesion region were selected followed by ROI analysis and histogram analysis. Statistical analysis was performed using Shapiro-Wilk's test, t tests, ANOVA with Tukey's post hoc test, and receiver operation characteristic (ROC) analysis. Results ICMLs showed significantly (p < 0.01) higher APT-w contrast in lesion compared with contralateral side. There was a substantial overlap between mean APT-w contrast of neoplastic and infective mass lesions as well as among different groups of ICMLs irrespective of ROI selection and normalizations. APT-w contrast (using type 4 normalization: normalized with reference signal at negative offset frequency and APT-w contrast in normal-appearing white matter) reduced variability of APT-w contrast across different subjects, and overlap was less compared with other types of normalizations. There was a significant difference (p < 0.05) between neoplastic and infective mass lesions using t test for different histogram parameters of type 4 normalized APT-w contrast. ANOVA with post hoc showed significant difference (p < 0.05) for different histogram parameters of APT-w contrast (Type 4 normalization) between LGG and HGG, LGG, and infective mass lesion. Histogram parameters such as standard deviation, mean of top percentiles, and median provided improved differentiation between neoplastic and infective mass lesions compared with mean APT-w contrast. A greater number of histogram parameters of type 4 normalized APT-w contrast corresponding to active lesion region can significantly differentiate between ICMLs than other types of normalizations and ROIs. Conclusions APT-w contrast using type 4 normalization and active lesion region (ROI-2) should be used for studying APT. APT-MRI should be combined with other MRI techniques to further improve the differential diagnosis of ICMLs.
机译:目的,评估酰胺质子转移加权(APT-W)磁共振成像(APT-W)在使用不同对比度训练,感兴趣区域(ROI)选择和直方图分析的肿瘤和感染质量病变中的作用。程序回顾性研究包括32例治疗 - 野生患者颅内质量病变(ICML):低级胶质瘤(LGG)= 14,高等胶质瘤(HGG)= 10,以及感染质量损伤= 8. APT-W MRI图像在3吨的常规MRI图像中获取APT-W对比度,校正B-0场不均匀性,而是相对于不同类型的训练计算和优化。选择不同的ROIS在病变区上,然后选择ROI分析和直方图分析。使用Shapiro-Wilk的测试,T测试,具有Tukey的Hoc测试的ANOVA进行统计分析,以及接收器操作特性(ROC)分析。结果ICMLS与对侧相比,病变的显着显着(P <0.01)较高的APT-W对比。无论ROI选择和训练如何,肿瘤和感染质量病变的平均值与感染质量病变的平均值与ICML之间存在相当大的重叠。 APT-W对比(使用类型4归一化:在负偏移频率下用参考信号归一化,并且正常出现的白质对比)降低了不同受试者的APT-W对比的可变性,与其他类型的重叠较少癌症。使用T检测对于类型4的不同直方图参数,肿瘤和感染质量病变之间存在显着差异(P <0.05),对于4型归一化APT-W对比度。具有后HOC的ANOVA表现出显着的差异(P <0.05),用于IPT-W对比度(4型归一化)在LGG和HGG,LGG和感染质量病变之间的不同直方图参数。直方图参数,如标准偏差,顶部百分位的平均值和中位数提供了与平均APT-W对比相比的肿瘤和感染质量病变之间的改善分化。对应于有源病变区域的4型归一化APT-W对比的大量直方图参数可以显着区分ICML,而不是其他类型的训练和ROI。结论APT-W采用4型标准化对比和有源病变区(ROI-2)应用于学习APT。 APT-MRI应与其他MRI技术相结合,以进一步改善ICML的差异诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号